The Utility of Mass Spectrometry in Defining Minimal Residual Disease in Treated Multiple Myeloma Patients

被引：0
|
作者：
Campbell, Lauren [1 ]
Lau, I-Jun [2 ]
Ramasamy, Karthik [3 ]
Sadler, Ross [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[2] Botnar Inst, Oxford, England
[3] Radcliffe Dept Med, Oxford, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-184
引用
收藏
页码：S144 / S145
页数：2
相关论文
共 50 条
  • [31] Evaluation of Minimal Residual Disease (MRD) Negativity in Patients with Relapsed or Refractory Multiple Myeloma Treated in the Candor Study
    Landgren, Ola
    Weisel, Katja
    Dachs, Laura Rosinol
    Moreau, Philippe
    Turgut, Mehmet
    Hajek, Roman
    Mollee, Peter
    Kim, Jin Seok
    Zhang, Jianqi
    Go, Ning
    Morris, Christopher L.
    Usmani, Saad Z.
    BLOOD, 2020, 136
  • [32] Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies
    Caroni, Federico
    Sammartano, Vincenzo
    Pacelli, Paola
    Sicuranza, Anna
    Malchiodi, Margherita
    Dragomir, Andreea
    Ciofini, Sara
    Raspadori, Donatella
    Bocchia, Monica
    Gozzetti, Alessandro
    PHARMACEUTICALS, 2025, 18 (02)
  • [33] Minimal residual disease in multiple myeloma: current status
    Ding, Hong
    Xu, Juan
    Lin, Zhimei
    Huang, Jingcao
    Wang, Fangfang
    Yang, Yan
    Cui, Yushan
    Luo, Hongmei
    Gao, Yuhan
    Zhai, Xinyu
    Pang, Weicui
    Zhang, Li
    Zheng, Yuhuan
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [34] MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA: IMAGING TECHNIQUES
    Zamagni, E.
    Tacchetti, P.
    Pantani, L.
    Mancuso, K.
    Zannetti, B.
    Rocchi, S.
    Rizzello, I
    Caratozzolo, I
    Nanni, C.
    Fanti, S.
    Cavo, M.
    HAEMATOLOGICA, 2018, 103 : 1 - 2
  • [35] Imaging Measurable (Minimal) Residual Disease in Multiple Myeloma
    Bhutani M.
    Usmani S.Z.
    Taneja A.
    Landgren O.
    Current Radiology Reports, 4 (12)
  • [36] Advances in minimal residual disease monitoring in multiple myeloma
    Wijnands, Charissa
    Noori, Somayya
    van de Donk, Niels W. C. J.
    VanDuijn, Martijn M.
    Jacobs, Joannes F. M.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2023, 60 (07) : 518 - 534
  • [37] Minimal residual disease in multiple myeloma: current status
    Hong Ding
    Juan Xu
    Zhimei Lin
    Jingcao Huang
    Fangfang Wang
    Yan Yang
    Yushan Cui
    Hongmei Luo
    Yuhan Gao
    Xinyu Zhai
    Weicui Pang
    Li Zhang
    Yuhuan Zheng
    Biomarker Research, 9
  • [38] Molecular detection of minimal residual disease in multiple myeloma
    Bai, Yinlei
    Orfao, Alberto
    Sang Chim, Chor
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 11 - 26
  • [39] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    HAEMATOLOGICA, 2024, 109 (07) : 2049 - 2059
  • [40] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2049 - 2059
12345